Triggering the resolution of immune mediated inflammatory diseases: can targeting leukocyte migration be the answer?
Research output: Contribution to journal › Article
Leukocyte recruitment is a pivotal process in the regulation and resolution of an inflammatory episode. It is vital for the protective responses to microbial infection and tissue damage, but is the unwanted reaction contributing to pathology in many immune mediated inflammatory diseases (IMIDs). Indeed, it is now recognized that patients with IMIDs have defects in at least one, if not multiple, check-points regulating the entry and exit of leukocytes from the inflamed site. In this review, we will explore our understanding of the imbalance in recruitment that permits the accumulation and persistence of leukocytes in IMIDs. We will highlight old and novel pharmacological tools targeting these processes in an attempt to trigger resolution of the inflammatory response. In this context, we will focus on cytokines, chemokines, known pro-resolving lipid mediators and potential novel lipids (e.g., sphingosine-1-phosphate), along with the actions of glucocorticoids mediated by 11-beta hydroxysteroid dehydrogenase 1 and 2.
|Number of pages||9|
|Journal||Frontiers in Pharmacology|
|Publication status||Published - 1 Mar 2019|
- leukocytes, migration, inflammation, resolution, PEPITEM, sphingosine-1-phosphate, glucocorticoids, 11-beta hydroxysteroid dehydrogenase